13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 46 holding rows worth $609,819,841.
- Accession
- 0001420506-26-001036
- Filer
- CIK 1617201
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 46 entries on the cover page, a total value of $609,819,841 stated on the cover page (in dollars after the unit check, H1), rows summing to $609,819,841 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 735,000 | $52,883,250 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 795,547 | $49,920,574 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 3,550,000 | $49,345,000 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 1,945,000 | $48,644,450 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 1,550,000 | $46,500,000 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 523,463 | $33,616,794 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 5,004,439 | $32,178,543 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 8,300,000 | $31,125,000 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,356,700 | $27,289,971 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 76,000 | $25,146,120 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 2,629,971 | $22,775,549 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 513,632 | $18,162,028 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 770,000 | $17,987,200 | dollars as filed | |
| VEEVA SYS INC CL A COM | 922475108 | Stock | 86,480 | $15,191,077 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 539,049 | $13,497,787 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 350,000 | $12,712,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 105,000 | $11,691,750 | dollars as filed | |
| CONCENTRA GROUP HOLDINGS PAR | 20603L102 | COMMON STOCK | 505,822 | $10,849,882 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 202,300 | $10,665,256 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 1,100,000 | $9,218,000 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 2,154,381 | $8,919,137 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 697,108 | $6,545,844 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 510,578 | $5,800,166 | dollars as filed | |
| EMERGENT BIOSOLUTIONS INC | 29089Q105 | COM | 639,118 | $5,304,679 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 180,000 | $4,986,000 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 302,399 | $4,799,072 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 175,825 | $4,367,493 | dollars as filed | |
| ICU MED INC | 44930G107 | COM | 27,450 | $3,545,168 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 79,872 | $2,468,844 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 683,856 | $2,448,204 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 241,123 | $2,170,107 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,667,600 | $2,101,176 | dollars as filed | |
| OMEROS CORP | 682143102 | COM | 174,800 | $1,845,888 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 4,000 | $1,843,960 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 515,754 | $1,763,879 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 250,244 | $1,704,162 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 200,000 | $1,676,000 | dollars as filed | |
| COYA THERAPEUTICS INC | 22407B108 | CMN | 420,360 | $1,656,218 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 45,000 | $1,464,300 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 10,000 | $1,180,200 | dollars as filed | |
| TRUEBLUE INC | 89785X101 | COM | 249,107 | $974,008 | dollars as filed | |
| IMMUNEERING CORP | 45254E107 | CLASS A COM | 123,409 | $650,365 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 5,000 | $623,250 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 50,400 | $549,360 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 411,600 | $535,080 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 5,000 | $497,050 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-001036 | this filing | 2026-05-15 | acceptance time not in the bulk data set |